Results 351 to 360 of about 9,631,724 (372)

Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention–sponsored Summit

Ca-A Cancer Journal for Clinicians, 2020
Samir Gupta, Gloria D Coronado, Alison T Brenner   +2 more
exaly  

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Martin G Pomper, Steven P Rowe
exaly  

Management of glioblastoma: State of the art and future directions

Ca-A Cancer Journal for Clinicians, 2020
Aaron C Tan, Giselle Y López, Mustafa Khasraw   +2 more
exaly  

Management of hyperthyroidism due to Graves’ disease: frequently asked questions and answers (if any)

Journal of Endocrinological Investigation, 2016
L. Bartalena, L. Chiovato, P. Vitti
semanticscholar   +1 more source

Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

Ca-A Cancer Journal for Clinicians, 2004
Robert A Smith, Evandro Novaes
exaly  

Controversies in the management of Graves’ disease in children

Journal of Endocrinological Investigation, 2016
S. Rivkees
semanticscholar   +1 more source

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Graves' disease in children.

Annales d'Endocrinologie, 2018
J. Léger, I. Oliver, D. Rodrigue, A. Lambert, R. Coutant   +4 more
semanticscholar   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Marsela Braunstein, Stephanie Lheureux, Amit M Oza   +2 more
exaly  

Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2018
Nancy D Perrier, Tf Duffield, R Michael Tuttle   +2 more
exaly